PP
ENFN

Paloma Partners’s Enfusion, Inc. ENFN Stock Holding History

Paloma Partners’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,544
Closed -$157K – 1143
2024
Q3 		$157K Buy
+16,544
New +$143K ﹤0.01% 1011

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paloma Partners's ENFN Position: Q4 2024 in Review

Paloma Partners sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 16,544 shares — an estimated $157K sold.

Paloma Partners first reported a position in ENFN in Q3 2024 and held it in 1 quarter. The position peaked at $157K in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • Paloma Partners reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 16,544 Enfusion, Inc. shares in Q4 2024, an estimated $157K.
  • Paloma Partners first reported a position in Enfusion, Inc. in Q3 2024 and held it in 1 quarter.
  • Paloma Partners's Enfusion, Inc. position peaked at $157K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.